Hasan Jafri
CIK 1815352 · Chief Medical Officer · last filed 2024-06-28
Hasan Jafri is a Chief Medical Officer who has filed 9 SEC Form 4 insider transactions across 1 company since 2020. Across all open-market trades the lifetime net is +$21.1K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
9
$21.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Aridis Pharmaceuticals, Inc. (ARDS) Delisted | Chief Medical Officer | 15,100 | $0.31 | $4.7K | $21.1K | 7 | 2023-06-15 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-28 | — | Grant (A) | — | $0 | |
| 2023-09-19 | — | Grant (A) | — | $0 | |
| 2023-06-15 | Aridis Pharmaceuticals, Inc. (ARDS) Delisted | Mixed | +10,000 | $0 | EDGAR |
| 2022-12-07 | Aridis Pharmaceuticals, Inc. (ARDS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-10-05 | Aridis Pharmaceuticals, Inc. (ARDS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-09-08 | Aridis Pharmaceuticals, Inc. (ARDS) Delisted | Buy (P) | +5,100 | $21.1K | EDGAR |
| 2021-04-02 | Aridis Pharmaceuticals, Inc. (ARDS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-25 | Aridis Pharmaceuticals, Inc. (ARDS) Delisted | Exer (M) | — | $0 | EDGAR |
| 2020-06-25 | Aridis Pharmaceuticals, Inc. (ARDS) Delisted | Grant (A) | — | $0 | EDGAR |